<DOC>
	<DOCNO>NCT02089269</DOCNO>
	<brief_summary>The registry aim collect analyse information antineoplastic treatment metastatic locally advanced pancreatic cancer daily routine practice Germany . The registry follow patient two year . It identify common sequence treatment use well change treatment disease . Health-related quality life analyse course treatment ( PanLife ) . Based available data prognostic score develop .</brief_summary>
	<brief_title>Tumor Registry Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Metastatic locally advance pancreatic cancer 18 year older Antineoplastic treatment Date consent later 2 week start firstline treatment No pancreatic cancer Below 18 year old No antineoplastic treatment Date consent later 2 week start firstline treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>pancreatic neoplasm</keyword>
	<keyword>neoplasm</keyword>
	<keyword>registry</keyword>
	<keyword>advanced pancreatic cancer</keyword>
	<keyword>health service research</keyword>
	<keyword>epidemiology</keyword>
	<keyword>Germany</keyword>
	<keyword>palliative treatment</keyword>
	<keyword>palliative care</keyword>
</DOC>